Literature DB >> 27462036

Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder.

Jessica Dagani1, Giulia Signorini1, Olav Nielssen2, Moira Bani1, Adriana Pastore3, Giovanni de Girolamo1, Matthew Large4.   

Abstract

OBJECTIVE: To evaluate the length of the interval between the onset and the initial management of bipolar disorder (BD).
METHOD: We conducted a meta-analysis using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Systematic searches located studies reporting estimates of the age of onset (AOO) and indicators of the age at initial management of BD. We calculated a pooled estimate of the interval between AOO and age at management. Factors influencing between-study heterogeneity were investigated using sensitivity analyses, meta-regression, and multiple meta-regression.
RESULTS: Twenty-seven studies, reporting 51 samples and a total of 9415 patients, met the inclusion criteria. The pooled estimate for the interval between the onset of BD and its management was 5.8 years (standardized difference, .53; 95% confidence interval, .45 to .62). There was very high between-sample heterogeneity ( I2 = 92.6; Q = 672). A longer interval was found in studies that defined the onset according to the first episode (compared to onset of symptoms or illness) and defined management as age at diagnosis (rather than first treatment or first hospitalization). A longer interval was reported among more recently published studies, among studies that used a systematic method to establish the chronology of illness, among studies with a smaller proportion of bipolar I patients, and among studies with an earlier mean AOO.
CONCLUSIONS: There is currently little consistency in the way researchers report the AOO and initial management of BD. However, the large interval between onset and management of BD presents an opportunity for earlier intervention.

Entities:  

Keywords:  age of onset; bipolar disorders; clinical management; duration of untreated bipolar disorder; meta-analysis

Mesh:

Year:  2016        PMID: 27462036      PMCID: PMC5407546          DOI: 10.1177/0706743716656607

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  53 in total

Review 1.  Comparison of long-term monitoring methods for bipolar affective disorder.

Authors:  M Hörn; L Schärer; S Walser; D Scherer-Klabunde; C Biedermann; J Walden
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

Review 2.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

4.  Use of treatment services and pharmacotherapy for bipolar disorder in a general population-based mental health survey.

Authors:  Ayal Schaffer; John Cairney; Amy H Cheung; Scott Veldhuizen; Anthony J Levitt
Journal:  J Clin Psychiatry       Date:  2006-03       Impact factor: 4.384

Review 5.  Early stages of bipolar disorder: characterization and strategies for early intervention.

Authors:  Adiel C Rios; Mariane N Noto; Lucas B Rizzo; Rodrigo Mansur; Flávio E Martins; Rodrigo Grassi-Oliveira; Christoph U Correll; Elisa Brietzke
Journal:  Braz J Psychiatry       Date:  2015 Oct-Dec       Impact factor: 2.697

6.  Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders.

Authors:  L Dell'Osso; H S Akiskal; P Freer; M Barberi; G F Placidi; G B Cassano
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

7.  Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder.

Authors:  Joseph F Goldberg; Carrie L Ernst
Journal:  J Clin Psychiatry       Date:  2002-11       Impact factor: 4.384

8.  Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).

Authors:  Hagop S Akiskal; Elie-Georges Hantouche; Jean-François Allilaire; Daniel Sechter; Marc L Bourgeois; Jean-Michel Azorin; Liliane Chatenêt-Duchêne; Sylvie Lancrenon
Journal:  J Affect Disord       Date:  2003-01       Impact factor: 4.839

9.  Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry.

Authors:  Suchat Paholpak; Ronnachai Kongsakon; Wasana Pattanakumjorn; Roongsang Kanokvut; Wiroj Wongsuriyadech; Manit Srisurapanont
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-15       Impact factor: 2.570

10.  Polarity of the first episode and time to diagnosis of bipolar I disorder.

Authors:  Boseok Cha; Jeong Hyun Kim; Tae Hyon Ha; Jae Seung Chang; Kyooseob Ha
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

View more
  23 in total

1.  Bipolar II Disorder: Frequent, Valid, and Reliable.

Authors:  Eduard Vieta
Journal:  Can J Psychiatry       Date:  2019-08       Impact factor: 4.356

2.  Age of Onset of Mental Disorders.

Authors:  Scott B Patten
Journal:  Can J Psychiatry       Date:  2017-04       Impact factor: 4.356

3.  Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences.

Authors:  Stacey Pereira; Katrina A Muñoz; Brent J Small; Takahiro Soda; Laura N Torgerson; Clarissa E Sanchez; Jehannine Austin; Eric A Storch; Gabriel Lázaro-Muñoz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2022-07-06       Impact factor: 3.358

4.  Change of Disease Spectrum Characteristics of Psychiatric Inpatients Before and After Lockdown Lifted During the COVID-19 Pandemic - Wuhan City, Hubei Province, China, 2021.

Authors:  Jingfang Liu; Xuan Gong; Xiaofen Li; Zhiying Wan; Hongqiang Sun; Lijun Kang; Zhongchun Liu
Journal:  China CDC Wkly       Date:  2022-05-06

5.  A Mixed-Methods Analysis of Mobile ACT Responses From Two Cohorts.

Authors:  Sydney Hoel; Amanda Victory; Tijana Sagorac Gruichich; Zachary N Stowe; Melvin G McInnis; Amy Cochran; Emily B K Thomas
Journal:  Front Digit Health       Date:  2022-05-12

6.  Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.

Authors:  Marco Solmi; Michele Fornaro; Edoardo G Ostinelli; Caroline Zangani; Giovanni Croatto; Francesco Monaco; Damir Krinitski; Paolo Fusar-Poli; Christoph U Correll
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

Review 7.  Pharmacological treatment of adult bipolar disorder.

Authors:  Ross J Baldessarini; Leonardo Tondo; Gustavo H Vázquez
Journal:  Mol Psychiatry       Date:  2018-04-20       Impact factor: 15.992

8.  The association between manic symptoms in adolescence and preschool symptoms: The importance of family history.

Authors:  Natchanan Charatcharungkiat; Joan Luby; Rebecca Tillman; Alecia Vogel
Journal:  Bipolar Disord       Date:  2021-02-10       Impact factor: 6.744

9.  Response to letters by Baethge et al. and Martino et al.

Authors:  Steven Marwaha; Andrew Thompson
Journal:  Int J Bipolar Disord       Date:  2017-07-08

10.  Mitochondrial Alterations in Fibroblasts of Early Stage Bipolar Disorder Patients.

Authors:  Ana P Marques; Rosa Resende; Diana F Silva; Mariana Batista; Daniela Pereira; Brigite Wildenberg; Sofia Morais; António Macedo; Cláudia Pais; Joana B Melo; Nuno Madeira; Cláudia F Pereira
Journal:  Biomedicines       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.